David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
YELIVA®, a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the ...
WASHINGTON, DC, March 28, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email